AN OPEN-LABEL, SINGLE-DOSE, MASS-BALANCE STUDY TO ASSESS THE DISPOSITION OF 14C-LABELED PRT054021 IN HEALTHY MALE SUBJECTS
Latest Information Update: 24 Jan 2013
At a glance
- Drugs Betrixaban (Primary)
- Indications Stroke; Thromboembolism
- Focus Pharmacokinetics
- Sponsors Portola Pharmaceuticals
- 24 Jan 2013 New trial record